Purchases and Sales Made in Q3 2024 in Immunovant, Inc. (IMVT)
This table provides information about the institutional ownership of Immunovant, Inc. (IMVT) during Q3 2024. The information is specifically focused on institutions that hold shares of Immunovant, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Stem Point Capital LP
New York, NY |
SELL
|
- |
-341K- 33.69% |
$9.38M - $9.38M
|
671K
$18.5M
|
|
|
Nov 14, 2024
Q3 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-350K- 74.03% |
$9.62M - $9.62M
|
123K
$3.38M
|
|
|
Nov 14, 2024
Q3 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-408K- 22.4% |
$11.2M - $11.2M
|
1.41M
$38.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-809K- 89.1% |
$22.3M - $22.3M
|
99K
$2.72M
|